AMPH - Amphastar Pharmaceuticals Inc Net earnings per share (EPS TTM)

Symbol and logo of brand Amphastar Pharmaceuticals, Inc. (AMPH)

The production of complex injectable generics provides Amphastar Pharmaceuticals (AMPH) with high margins and operational leverage as volumes grow. However, FDA delays and price erosion create risks for profitability. The company is implementing innovative peptides and drug delivery systems. The current rolling annual EPS reflects earnings dynamics, with the current mark equal to 2.20.

AMPH (Amphastar Pharmaceuticals) Net earnings per one share for the last twelve months history from 07/04/2022 to 11/15/2026

Summary analytical data breakdowns for Amphastar Corp (AMPH)

- share price and expert price forecast:
Stock Quotes Amphastar Pharmaceuticals|AMPH - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Amphastar Corp|AMPH - Value Adjusted for Debt and Cash
- business book valuation details:
Book Value per Share Amphastar Pharmaceuticals|AMPH - Total Stockholders' Equity|Market Value to Book Value Ratio amphastar.com|AMPH - Aggregate Asset Value
- debt obligations and liquidity statistics:
Total Debt to Capital Amphastar Pharmaceuticals|AMPH - Long-Term Debt to Capital|Short-Term Debt to Equity amphastar.com|AMPH - Company Total Debt|Debt to Book Capitalization Ratio Amphastar Pharmaceuticals Inc|AMPH - Long-Term Liabilities|Company Short-Term Debts Amphastar Pharmaceuticals|Quick Ratio amphastar.com
- net income and valuation multiples indicators:
AMPH - Net Profit|Expected Profit Amphastar Pharmaceuticals|AMPH - Business Payback Period|Projected Price to Earnings Amphastar Pharmaceuticals, Inc.|AMPH - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Amphastar Pharmaceuticals Inc|AMPH - Operating profit EBITDA|Earnings per share for the last twelve months Amphastar Pharmaceuticals|AMPH - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months amphastar.com|AMPH - Earnings per share increase in current year|Net earnings per share growth forecast for next year Amphastar Pharmaceuticals
- revenue and sales proceeds data:
AMPH - Company Annual Revenue|Projected Sales Volume Amphastar Pharmaceuticals, Inc.|AMPH - Market Capitalization-to-Revenue Ratio|Forward P/S Multiple Amphastar Pharmaceuticals Inc|AMPH - Sales Growth YoY (TTM)
Initial company analysis:AMPH - Amphastar Pharmaceuticals
Manufactured products of Amphastar

Trailing twelve-month net income per share reflects the actual efficiency of capital generation per common share, eliminating the volatility of quarterly reports. For Amphastar Pharmaceuticals (AMPH), this trailing annual earnings per share demonstrates how successfully the transition to proprietary drug delivery systems mitigates the risks of dependence on a narrow segment of injectable generics, thereby determining the fair value of the business.

Key competitors

Haleon - Net earnings per share (EPS TTM)|Kenvue - Earnings per share for the last four quarters|VRNA: Net earnings per share (EPS TTM)|Jyong Biotech Corp - Earnings per share for the trailing year|LGND (Ligand Pharmaceuticals Incorporated) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months amneal.com AMRX|Earnings per share for the last twelve months Perrigo (PRGO)|ALVO (Alvotech SA) - Earnings per share for the trailing year|Earnings per share for the last twelve months Liquidia Technologies LQDA|Net earnings per share for the trailing year Galapagos Genomics|ANIP - Earnings per share for the last twelve months|MNKD - Net earnings per share (EPS TTM)|PCRX: Net earnings per share (EPS TTM)|SPRY - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Theravance|Net earnings per one share for the last twelve months Aquestive Corp AQST|Net earnings per share (EPS TTM) SCPH|TECX - Net earnings per one share for the last twelve months|Tonix Pharmaceuticals Holding Corp. - Net earnings per share for the last 12 months|Earnings per share for the trailing year SXTC|Eupraxia Pharmaceuticals, Inc. - Net earnings per share (EPS TTM)|BHST: Earnings per share for the last twelve months|invizyne.com (EXOZ) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ORMP (Oramed)|ENTX (Entera Bio) - Net earnings per share (EPS TTM)|HYFT: Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC|Cumberland Pharmaceuticals - Earnings per share for the last 12 months|Earnings per share for the last twelve months Quantum BioPharma Ltd. QNTM|FGEN: Earnings per share for the last 12 months|TELO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Rani Therapeutics Holdings|SNYR: Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months RLYB (Rallybio Corp.)|LEXX (Lexaria Bioscience Corp.) - Net earnings per share (EPS TTM)|pulmatrix.com (PULM) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pheton (PTHL)|Net earnings per share for the last four quarters Aptorum Group Ltd|Net earnings per share (EPS TTM) LYRA (Lyra Therapeutics Inc)|Impact BioMedical - Earnings per share for the last twelve months|TNF Pharmaceuticals - Net earnings per share (EPS TTM)|YCBD - Net earnings per share (EPS TTM)|PRFX: Net earnings per share (EPS TTM)|CYTO: Earnings per share for the last four quarters|LIPO (Lipella Pharma) - Net earnings per share (EPS TTM)|OPTN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PIRS|PROC (procapsgroup.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding - Earnings per share for the last twelve months|SLRN - Earnings per share for the last twelve months|Earnings per one share for the last 12 months TFFP